Murphy USA heads into the week of June 9 with a sharp and unusual tension: short sellers are rebuilding positions at the fastest pace in months, yet the stock just posted its best weekly gain in recent memory.
The short-side move is the standout data point this week. Short interest jumped 25% in a single week to reach 6.1% of the free float — roughly 1.14 million shares — with almost all of that increase arriving in one session on June 9, when estimated shorts surged 24% in a day. That kind of step-change typically reflects either a fresh directional bet or a hedge being established ahead of an event. The next earnings print is scheduled for July 29, which may be drawing early attention. Borrow conditions offer no resistance to the buildup: availability is exceptionally loose at roughly 2,580% — meaning there are more than 25 shares available to borrow for every one already shorted — and cost to borrow has halved this week to a negligible 0.15%. New short positions are easy and cheap to establish. Options positioning has shifted slightly more cautious in parallel, with the put/call ratio at 0.60, running about 1.7 standard deviations above its 20-day average of 0.52. That is not an alarm signal on its own — the 52-week high PCR is 1.52 — but it does align directionally with the short-side rebuild.
The Street picture is more supportive than the short-side activity implies. Analyst moves following the April 29 earnings release were broadly constructive: targets moved higher across the board, with Keybanc lifting to $600 and maintaining Overweight, Wells Fargo raising to $520 from $450, and RBC bumping modestly to $517. Bank of America made the most notable pivot, upgrading from Underperform to Neutral and raising its target from $350 to $550 — a signal that the bear case lost conviction after the print. The mean target now sits at $558, virtually in line with Monday's close of $556. That tight gap between price and consensus target is itself a data point: the Street is not stretched on valuation, but it is not projecting meaningful further upside at current levels. At 18x trailing earnings and 11.3x EV/EBITDA, multiples have drifted modestly lower over the past month, suggesting the rally has been more price-action driven than a multiple re-rating. Factor scores reinforce a mixed picture: EPS surprise ranks in the 81st percentile and 90-day earnings momentum is strong at the 87th percentile, but forward earnings growth ranks in only the 19th percentile — bulls are extrapolating from a strong recent track record into a less certain outlook.
The insider activity adds a note of caution worth registering. Every trade logged in the past 90 days has been a sale. Two directors — Diane Landen and James Keyes — sold a combined $2.8 million of stock in the first week of June, both at prices between $511 and $547. SVPs also trimmed throughout May. The 90-day net figure is positive in shares (around 51,000 net) but that reflects the size of existing holdings rather than new buying; no insider has added to a position in the visible window. Concentrated insider selling into a strong price recovery is a data point the short rebuilders may be responding to.
The earnings history makes the July 29 date worth marking. The most recent Q1 print on April 29-30 produced a one-day move of roughly 13-16% — a large reaction by any measure, with a five-day follow-through of around 11-13%. That pattern suggests the options market has historically underpriced MUSA's earnings moves. Whether the current short rebuild is anticipating a reversal of that post-earnings strength, or simply hedging a position that has gained nearly 6% in a week, is what the July 29 release will clarify.
See the live data behind this article on ORTEX.
Open MUSA on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data. Content is informational only and does not constitute investment advice.
